NEW YORK ( TheStreet) -- CHANGE IN RATINGSAlbermarle ( ALB) was downgraded at Sterne Agee to neutral from buy. Estimates were also cut, given a slower growth outlook, Sterne Agee said. Align Technology ( ALGN) was upgraded at Cantor Fitzgerald to buy from hold. $60 price target. Volume and pricing trends are improving, Cantor said. Advanced Micro ( AMD) was downgraded at Bank of America/Merrill Lynch to neutral from buy. Company remains leveraged to slower PC growth, BofA/Merrill said. $4.50 price target. Amazon.com ( AMZN) was upgraded at UBS to buy from neutral. Bullish secular backdrop for multichannel commerce accelerates revenue growth, UBS said. $385 price target. Alpha Natural ( ANR) was downgraded at BMO Capital to underperform from market perform. $4 price target. Expect to see more production cuts at the company, BMO Capital said.
AthenaHealth ( ATHN) was upgraded at Sterne Agee to buy. $132 price target. Estimates also upped, as core sales growth should accelerate in the coming quarters, Sterne Agee said. Aspen Technology ( AZPN) was downgraded at J.P. Morgan to neutral from overweight. $38 price target. Valuation call, J.P. Morgan said. Baxter ( BAX) was downgraded at Morgan Stanley to equal-weight from overweight. Estimates were also cut, given lower expected Advate growth, Morgan Stanley said. Peabody Energy ( BTU) was upgraded at BMO Capital to outperform from market perform. $23 price target. Costs are coming down in Australia and the stock is attractively valued, BMO Capital said.
CBOE Holdings ( CBOE) was upgraded at UBS to buy from neutral. Strong secular growth and valuation call, UBS said. $56 price target. Cypress Semiconductor ( CY) was upgraded at Pacific Crest to sector perform from outperform. Valuation call, based on an $11 price target. Essex Property Trust ( ESS) was upgraded at UBS to buy from neutral. High exposure to strong rental growth in West Coast and promising development pipeline in CA, UBS said. Valuation call, $180 price target. Fairchild Semiconductor ( FCS) was downgraded at Canaccord Genuity to hold. Company offered a soft outlook for the fourth quarter and lacks near-term catalysts, Canaccord said. $12 price target. Finish Line ( FINL) was initiated with a neutral rating and $25 price target at UBS.